News

News about advances made possible through IPIRA's work, such as innovations commercialized, campus partnerships with industry, and companies born out of licensing UC Berkeley intellectual property rights.

All News

November 9, 2014

Caribou co-Founder, Jennifer Doudna Wins Medical Breakthrough Prize

Link

October 7, 2014

Airlines Fly the Skies on a Sugar High

Link

October 2, 2014

Catalent Acquires Redwood Bioscience Inc. And The SMARTag™ Technology Platform

Link

October 1, 2014

Ekso Bionics to manufacture 80 ekoskeleton suits for veterans

Link

September 10, 2014

Stanford StartX & Mission Bay Capital Invest $1.86M in U.C. Berkeley Spin-out for Single Cell Analysis

Link

Zephyrus Biosciences secures $1.86M in funding to develop and commercialize its powerful single cell analysis

Link

August 12, 2014

First antimalarial treatments produced with semisynthetic artemisinin enter market

http://www.path.org/news/press-room/685/

July 21, 2014

Aduro BioTech Receives Breakthrough Designation from FDA for Innovative Pancreatic Cancer Combination Therapy

Link

July 15, 2014

Chirp Microsystems included in 60 Hot Startups to Watch

Link

June 16, 2014

Imprint Energy Secures $6M Series A Financing Led by Phoenix Venture Partners

Link

June 11, 2014

Aduro Biotech Secures $55M Series C financing

http://www.businesswire.com/news/home/20140611006115/en/Aduro-BioTech-Se...

May 27, 2014

Tiny brain device scores Bay Area grant from Obama's BRAIN initiative

Link

April 10, 2014

Kessler Foundation Selects Ekso GT for Pilot Study on Robotics in Mobility

Link

February 13, 2014

Ekso Bionics(TM) Named One of "5 Startups Poised to Change MedTech Forever"

Link

February 6, 2014

Speeding Up DNA Analysis

Link

January 15, 2014

Ekso Bionics Goes Public, Raises $20.6M

Link

January 8, 2014

Science magazine calls Berkeley discoveries top breakthroughs of 2013

Link

KineMed prepares for $51 million IPO

Link

January 2, 2014

Genocea files IPO papers in a bid to raise $75M for vaccine development

Link

November 14, 2013

Aduro Presents Preclinical Data on Enhanced Anti-Tumor Activity with Small-Molecule Immunotherapy Program

Link